Skip to main content
. 2022 Mar 9;12:854879. doi: 10.3389/fcimb.2022.854879

Figure 2.

Figure 2

BAs influence GM in NAFLD. (BAs, bile acids; CA, Cholic acid; CDCA, Chenodeoxycholic acid; C3GnT, Core 3 O-glycan; DCA, deoxycholic acid; FXR, farnesoid X receptor; Muc2, mucin 2; NAFLD, non-alcoholic fatty liver disease; G-β-MCA, glycine-β-muricholic acid; TUDCA, tauro-ursodeoxycholic).